Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain.

MLA

Keehan, Laura, et al. “Wide Range of Phenotypic Severity in Individuals with Late Truncations Unique to the Predominant CDKL5 Transcript in the Brain.” American Journal of Medical Genetics. Part A, vol. 188, no. 12, Dec. 2022, pp. 3516–24. EBSCOhost, https://doi.org/10.1002/ajmg.a.62940.

APA

Keehan, L., Haviland, I., Gofin, Y., Swanson, L. C., El Achkar, C. M., Schreiber, J., VanNoy, G. E., O’Heir, E., O’Donnell, L. A., Lewis, R. A., Magoulas, P., Tran, A., Azamian, M. S., Chao, H., Pham, L., Samaco, R. C., Elsea, S., Thorpe, E., Kesari, A., & Perry, D. (2022). Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain. American Journal of Medical Genetics. Part A, 188(12), 3516–3524. https://doi.org/10.1002/ajmg.a.62940

Chicago

Keehan, Laura, Isabel Haviland, Yoel Gofin, Lindsay C. Swanson, Christelle Moufawad El Achkar, John Schreiber, Grace E. VanNoy, et al. 2022. “Wide Range of Phenotypic Severity in Individuals with Late Truncations Unique to the Predominant CDKL5 Transcript in the Brain.” American Journal of Medical Genetics. Part A 188 (12): 3516–24. doi:10.1002/ajmg.a.62940.